These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 18252210)

  • 1. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.
    Wang G; van der Walt JM; Mayhew G; Li YJ; Züchner S; Scott WK; Martin ER; Vance JM
    Am J Hum Genet; 2008 Feb; 82(2):283-9. PubMed ID: 18252210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the rs12720208 single-nucleotide polymorphism of the FGF20 gene in Russian patients with sporadic Parkinson's disease].
    Ustinova VV; Shadrina MI; Fedotova EIu; Illarioshkin SN; Limborskaia SA; Slominskiĭ PA
    Genetika; 2012 Dec; 48(12):1437-9. PubMed ID: 23516905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.
    de Mena L; Cardo LF; Coto E; Miar A; Díaz M; Corao AI; Alonso B; Ribacoba R; Salvador C; Menéndez M; Morís G; Alvarez V
    Neurosci Lett; 2010 Jul; 479(1):22-5. PubMed ID: 20471450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.
    Wider C; Dachsel JC; Soto AI; Heckman MG; Diehl NN; Yue M; Lincoln S; Aasly JO; Haugarvoll K; Trojanowski JQ; Papapetropoulos S; Mash D; Rajput A; Rajput AH; Gibson JM; Lynch T; Dickson DW; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
    Mov Disord; 2009 Feb; 24(3):455-9. PubMed ID: 19133659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population.
    Haghnejad L; Emamalizadeh B; Jamshidi J; Bidoki AZ; Ghaedi H; Ahmadi E; Abdollahi S; Shahmohammadibeni N; Taghavi S; Fazeli A; Motallebi M; Zarneh AE; Mohammadihosseinabad S; Abbaszadegan MR; Torkamandi S; Gavenaroudi MA; Pedram N; Shahidi GA; Tafakhori A; Darvish H; Movafagh A
    J Neurol Sci; 2015 Aug; 355(1-2):72-4. PubMed ID: 26070653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.
    Zhao X; Wu Y; Zhao C; Feng M
    Neurol Sci; 2016 Jul; 37(7):1119-26. PubMed ID: 27023076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.
    Quan W; Li J; Liu L; Zhang Q; Qin Y; Pei X; Chen J
    Neurol Sci; 2022 May; 43(5):3145-3152. PubMed ID: 34845561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.
    Tagliafierro L; Glenn OC; Zamora ME; Beach TG; Woltjer RL; Lutz MW; Chiba-Falek O
    Alzheimers Dement; 2017 Nov; 13(11):1237-1250. PubMed ID: 28431219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of the effect of FGF20 rs12720208 variant on the risk of Parkinson's disease: a meta-analysis.
    Wang X; Sun X; Zhang X; Li H; Xie A
    Neurol Res; 2017 Apr; 39(4):374-380. PubMed ID: 28191856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.
    van der Walt JM; Noureddine MA; Kittappa R; Hauser MA; Scott WK; McKay R; Zhang F; Stajich JM; Fujiwara K; Scott BL; Pericak-Vance MA; Vance JM; Martin ER
    Am J Hum Genet; 2004 Jun; 74(6):1121-7. PubMed ID: 15122513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
    Sadhukhan D; Das G; Biswas A; Ghosh S; Das SK; Ray K; Ray J
    Neurosci Lett; 2018 May; 675():68-73. PubMed ID: 29604408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 20 polymorphism in sporadic Parkinson's disease in Northern Han Chinese.
    Xu X; Wang N; Xu H; Xie A; Jiang H; Xie J
    J Clin Neurosci; 2013 Nov; 20(11):1588-90. PubMed ID: 23938014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.
    Mizuta I; Tsunoda T; Satake W; Nakabayashi Y; Watanabe M; Takeda A; Hasegawa K; Nakashima K; Yamamoto M; Hattori N; Murata M; Toda T
    Hum Genet; 2008 Aug; 124(1):89-94. PubMed ID: 18568448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 20 (FGF20) polymorphism is a risk factor for Parkinson's disease in Chinese population.
    Pan J; Li H; Wang Y; Ma JF; Zhang J; Wang G; Liu J; Wang XJ; Xiao Q; Chen SD
    Parkinsonism Relat Disord; 2012 Jun; 18(5):629-31. PubMed ID: 22342445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.
    Zhu R; Zhu Y; Liu X; He Z
    Neurol Sci; 2014 Dec; 35(12):1889-94. PubMed ID: 24942208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-gene interaction between FGF20 and MAOB in Parkinson disease.
    Gao X; Scott WK; Wang G; Mayhew G; Li YJ; Vance JM; Martin ER
    Ann Hum Genet; 2008 Mar; 72(Pt 2):157-62. PubMed ID: 18205889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-486-3p Influences the Neurotoxicity of a-Synuclein by Targeting the SIRT2 Gene and the Polymorphisms at Target Sites Contributing to Parkinson's Disease.
    Wang Y; Cai Y; Huang H; Chen X; Chen X; Chen X; Mai H; Li X; Zhao J; Yang J; Fan W; Tang P; Chen Y; Li K; Cui L
    Cell Physiol Biochem; 2018; 51(6):2732-2745. PubMed ID: 30562735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms are associated with a functional polymorphism in a miR-433 binding site in the FGF20 gene.
    Jiménez KM; Pereira-Morales AJ; Adan A; Lopez-Leon S; Forero DA
    Mol Brain; 2018 Sep; 11(1):53. PubMed ID: 30241547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in FGF20 modulates hippocampal biology.
    Lemaitre H; Mattay VS; Sambataro F; Verchinski B; Straub RE; Callicott JH; Kittappa R; Hyde TM; Lipska BK; Kleinman JE; McKay R; Weinberger DR
    J Neurosci; 2010 Apr; 30(17):5992-7. PubMed ID: 20427658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of FGF20 in Chinese patients with Parkinson's disease.
    Sun XY; Wang L; Cheng L; Li NN; Lu ZJ; Li JY; Peng R
    Neurol Sci; 2017 May; 38(5):887-891. PubMed ID: 28238162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.